国产农村A片精品视频,操老女人91老熟女老妇女,91精品国产99久久久久久女少,精品韩国AV无码一区,婷婷色情乱婬一区二区三区小说
您好!博飛美科試劑歡迎您! 400-608-7598

利福平,97%

Rifampicin
博飛美科提供的所有產(chǎn)品僅用于科研等非醫(yī)療用途,非藥品不可食用,不可用于人體或動物的臨床診斷和治療,我們不為個人提供產(chǎn)品及服務。如您需要產(chǎn)品COA等資料,可至下方“質(zhì)量控制”中下載
PA79040
PERFEMIKER
13292-46-1
C43H58N4O12
822.94
品牌 貨號 包裝 純度 目錄價 會員價 庫存 數(shù)量 購買車
PERFEMIKER PA79040-250mg 250mg 97% ¥25.48 登錄可見優(yōu)惠價格
PERFEMIKER PA79040-1g 1g 97% ¥37.24 登錄可見優(yōu)惠價格
PERFEMIKER PA79040-5g 5g 97% ¥63.70 登錄可見優(yōu)惠價格
PERFEMIKER PA79040-25g 25g 97% ¥194.04 登錄可見優(yōu)惠價格
PERFEMIKER PA79040-100g 100g 97% ¥598.78 登錄可見優(yōu)惠價格
PERFEMIKER PA79040-500g 500g 97% ¥2712.64 登錄可見優(yōu)惠價格
產(chǎn)品名稱: 利福平,97%
中文別名: 利福平;甲哌力復霉素;利福霉素-S;3-(((4-甲基-1-哌嗪基)亞氨基)甲基)-利福霉素;異丁哌力復霉素;異丁基哌嗪利福霉素;利福霉素SV;力復霉素SV;利福霉素SV鈉;利福;利福定;利福霉素;利福平 EP標準品;利福平 USP標準品;利福平 標準品;利福平雜質(zhì)對照品;利福平(低溫保存);利福平-13C-D3;3-[[(4-甲基-1-哌嗪基)亞氨基]甲基]-利福霉素;甲哌利福霉素;抗厭氧菌藥;樹脂天青;3-(4-甲基-1-哌嗪基亞胺甲基)利福霉素SV;利米定;雷發(fā)平;力復平;立福平;力復霉素;利福平粉;利福平晶體;Rifampicin 利福平;利福平溶液
英文名稱: Rifampicin
英文別名: rifampicin;3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin;Abrifam;Dipicin;Eremfat;RIF;Rifa;Rifadin;Rifadin I.V.;Rifaldin;rifaldazine;Rifamate;Rifamicin AMP;Rifampin;Rifaprodin;Rifater;Rifobac;Rifoldin;Riforal;Rimactan;Rimycin;Rifamycin SV;Rifamycin SV Sodium;Rifandin;3-(4-METHYLPIPERAZINYLIMINOMETHYL)RIFAMYCIN SV;RIFAMPICIN(RG);3-(4-Methylpiperazinyliminomethyl)rifamycin SV,Rifampin,Rifamycin AMP;AMP;arficin;FaMcin;Resazurin;rifagen;Rifamycin AMP;rifinah;3-[[(4-methyl-1-piperazinyl)imino]methyl]-rifamycin;ARHF;RHOF;l-5103;Rimactane;Rifampicinum;Tubocin;Rifoldine;Rimactizid;Archidyn;Rimazid;Rifampicin SV;R/AMP;Rifampicina;Rifamor;Benemicin;Sinerdol;Rifadine;Rifaldazin;Rimactazid;Fenampicin;Doloresum;Rifcin;Arzide;Rifam;Dione 21-acetate;Rifampicine [French];Rifampicinum [INN-Latin];Ba 41166/E;Rifampicina [INN-Spanish];3-(((4-Methyl-1-piper;Rifampicin;SR-05000002118-3;SR-05000002118-3;5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-, 21-acetate;5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-, 21-acetate;HMS3713J11;HMS3713J11;2,7-(EPOXYPENTADECA(1,11,13)TRIENIMINO)NAPHTHO(2,1-B)FURAN-1,11(2-H)-DIONE, 5,6,9,17,19,21-HEXAHYDROXY-23-METHOXY-2,4,12,1///;2,7-(EPOXYPENTADECA(1,11,13)TRIENIMINO)NAPHTHO(2,1-B)FURAN-1,11(2-H)-DIONE, 5,6,9,17,19,21-HEXAHYDROXY-23-METHOXY-2,4,12,1///;RIFAMPICIN [INN];RIFAMPICIN [INN];Rimactane (TN);Rimactane (TN);rifamcin;rifamcin;Reserpine & Rifampicin;Reserpine & Rifampicin;HMS1569J11;HMS1569J11;Rifamsolin;Rifamsolin;BDBM50370232;BDBM50370232;GR-306;GR-306;Rifampicin, European Pharmacopoeia (EP) Reference Standard;Rifampicin, European Pharmacopoeia (EP) Reference Standard;RIFAMPICIN (IARC);RIFAMPICIN (IARC);RIFAMPICIN (EP IMPURITY);RIFAMPICIN (EP IMPURITY);RIFAMPICIN [JAN];RIFAMPICIN [JAN];RIFAMYCIN AMP [MI];RIFAMYCIN AMP [MI];C06688;C06688;D00211;D00211;Rifampicine;Rifampicine;(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-Pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(4-methylpiperazin-1-yliminomethyl)-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-21-yl acetate;(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-Pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(4-methylpiperazin-1-yliminomethyl)-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-21-yl acetate;RIFAMPIN COMPONENT OF RIFATER;RIFAMPIN COMPONENT OF RIFATER;Rifampicin, >=97% (HPLC), powder;Rifampicin, >=97% (HPLC), powder;Rifampicin in combination with actinonin, BB-3497, hydroxylamine hydrochloride, and 1,10-phenanthroline;Rifampicin in combination with actinonin, BB-3497, hydroxylamine hydrochloride, and 1,10-phenanthroline;NSC-113926;NSC-113926;CHEMBL374478;CHEMBL374478;2,11,13]trienimino)naphtho[2,1-b]f...
品牌: PERFEMIKER
CAS號: 13292-46-1
分子式: C43H58N4O12
分子量: 822.94
純度: 97%
詳細描述: 博飛美科的利福平,97%為抗生素,產(chǎn)品穩(wěn)定,定制速度快,極大地方便了廣大科研客戶的使用需求。產(chǎn)品包裝為5g。查詢關鍵詞:抗生素,13292-46-1,利福平,97%,Rifampicin,博飛美科,Perfemiker,上海,廠家現(xiàn)貨。
暫無相關參考文獻
搜索質(zhì)檢報告(COA)